Gland Pharma jumps 7% intraday despite weak Q3 performance; brokerage sees 26% upside
The buying sentiment in stock can mainly be attributed to improved gross and net margins sequentially in the December quarter despite weak revenue, as per YES Securities.
Gland Pharma share price, Gland Pharma price target, Gland Pharma Q3 earnings, pharma sector - Image Source: Pixabay